Publications: Prof Borislava Mihaylova
Zhou J, Wu R, Williams C, Emberson J, Reith C, Keech A, Robson J, Wilkinson K et al.
(
2023
)
.
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK
.
Pharmacoeconomics
Thalmann I, Preiss D, Schlackow I, Gray A, Mihaylova B
(
2023
)
.
Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017
.
Heart (British Cardiac Society)
vol.
109
,
(
5
)
388
-
395
.
Roukas C, Miller L, Hamborg T, Gordeev V, Lindsay J, Norton C, Mihaylova B
(
2023
)
.
DOP23 Decrements in quality of life associated with symptoms of Inflammatory Bowel Disease: results from the UK IBD-BOOST survey
.
Journal of Crohn's and Colitis
vol.
17
,
(
Supplement_1
)
i87
-
i88
.
Hart A, Miller L, Hamborg T, Stagg I, McGuinness S, Wileman V, Tzorovili E, Mihaylova B et al.
(
2023
)
.
DOP59 What is the relationship between fatigue, pain and urgency in people with inflammatory bowel disease? Results of the IBD-BOOST survey in 8486 participants
.
Journal of Crohn's and Colitis
vol.
17
,
(
Supplement_1
)
i130
-
i132
.
Williams C, Lui N, Bowman L, Gray A, Hopewell J, Landray M, Mihaylova B
(
2022
)
.
MSR45 Challenges in Extrapolation When There Are Multiple Health Outcomes
.
Value in Health
vol.
25
,
(
12
)
Jumbe S, Madurasinghe VW, James WY, Houlihan C, Jumbe SL, Yau T, Tomini F, Eldridge S et al.
(
2022
)
.
STOP— a training intervention to optimise treatment for smoking cessation in community pharmacies: cluster randomised controlled trial
.
BMC Medicine
vol.
20
,
(
1
)
Keng MJ, Leal J, Bowman L, Armitage J, Mihaylova B
(
2022
)
.
Hospital costs associated with adverse events in people with diabetes in the UK
.
Diabetes, Obesity and Metabolism
vol.
24
,
(
11
)
2108
-
2117
.
Thalmann I, Preiss D, Schlackow I, Gray A, Mihaylova B
(
2022
)
.
Antiplatelet therapy use for the secondary prevention of cardiovascular disease in 2009–2017: a population-wide retrospective cohort study of Scotland
.
European Heart Journal
vol.
43
,
(
Supplement_2
)
Wu R, Williams C, Zhou J, Schlackow I, Emberson J, Reith C, Keech A, Robson J et al.
(
2022
)
.
Benefit accrual with cardiovascular disease prevention and effects of discontinuation: a modelling study
.
European Heart Journal
vol.
43
,
(
Supplement_2
)
Mihaylova B, Wu R, Williams C, Zhou J, Schlackow I, Emberson J, Reith C, Keech A et al.
(
2022
)
.
Cost-effectiveness of statin therapy in categories of patients in the UK
.
European Heart Journal
vol.
43
,
(
Supplement_2
)
Zhou J, Wu R, Williams C, Emberson J, Reith C, Keech A, Robson J, Wilkinson K et al.
(
2022
)
.
Impact of cardiovascular events on primary and hospital care costs: findings from UK Biobank study
.
European Heart Journal
vol.
43
,
(
Supplement_2
)
Cholesterol Treatment Trialists' Collaboration
(
2022
)
.
Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials
.
Lancet
vol.
400
,
(
10355
)
832
-
845
.
Schmierer K, Baker D, Nawaz T, Allen-Philbey K, Barkhof F, Chataway J, Hooper R, Mihaylova B et al.
(
2022
)
.
153 ChariotMS – cladribine to halt deterioration in people with advanced multiple sclerosis (pwAMS)
.
Journal of Neurology Neurosurgery & Psychiatry
.
vol.
93
,
Roukas C, Syred J, Gordeev VS, Norton C, Hart A, Mihaylova B
(
2022
)
.
Development and test-retest reliability of a new, self-report questionnaire assessing healthcare use and personal costs in people with inflammatory bowel disease: The Inflammatory Bowel Disease Resource Use Questionnaire (IBD-RUQ)
.
Frontline Gastroenterology
vol.
14
,
(
1
)
59
-
67
.
Castellani J, Kimbute O, Makasi C, Mrango ZE, Paulus ATG, Evers SMAA, Hardy P, Sumner T et al.
(
2022
)
.
Daily Life and Challenges Faced By Households With Permanent Childhood Developmental Disability in Rural Tanzania – A Qualitative Study
.
Journal of Developmental and Physical Disabilities
vol.
34
,
(
3
)
471
-
490
.
Sammons E, Hopewell JC, Chen F, Stevens W, Wallendszus K, Valdes-Marquez E, Dayanandan R, Knott C et al.
(
2022
)
.
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease
.
European Heart Journal
vol.
43
,
(
14
)
1416
-
1424
.
Keng MJ, Armitage J, Bowman L, Leal J, Mihaylova B
(
2022
)
.
IDF21-0188 Impact of adverse events on hospital costs and health-related quality of life in people with diabetes
.
Diabetes Research and Clinical Practice
vol.
186
,
Keng MJ, Leal J, Bowman L, Armitage J, Mihaylova B
(
2022
)
.
Decrements in health-related quality of life associated with adverse events in people with diabetes
.
Diabetes, Obesity and Metabolism
vol.
24
,
(
3
)
530
-
538
.
Keng MJ, Leal J, Mafham M, Bowman L, Armitage J, Mihaylova B
(
2022
)
.
Performance of the UK Prospective Diabetes Study Outcomes Model 2 in a Contemporary UK Type 2 Diabetes Trial Cohort
.
Value in Health
vol.
25
,
(
3
)
435
-
442
.
Levy M, Chen Y, Clarke R, Guo Y, Lv J, Yu C, Li L, Chen Z et al.
(
2022
)
.
Gender differences in use of invasive diagnostic and therapeutic procedures for acute ischaemic heart disease in Chinese adults
.
Heart
vol.
108
,
(
4
)
292
-
299
.
Azhir A, Talebi S, Merino LH, Li Y, Lukasiewicz T, Argulian E, Narula J, Mihaylova B
(
2022
)
.
BEHRTDAY: Dynamic Mortality Risk Prediction using Time-Variant COVID-19 Patient Specific Trajectories
.
AMIA ... Annual Symposium proceedings. AMIA Symposium
vol.
2022
,
120
-
129
.
Wu R, Williams C, Schlackow I, Zhou J, Emberson J, Reith C, Keech A, Robson J et al.
(
2022
)
.
CALIBRATING CARDIOVASCULAR DISEASE POLICY MODEL USING LARGE COHORT DATA
.
VALUE IN HEALTH
.
vol.
25
,
S16
-
S16
.
Zhou J, Wu R, Williams C, Mihaylova B
(
2022
)
.
EXCESS ANNUAL HOSPITAL COSTS DUE TO CARDIOVASCULAR EVENTS IN A CONTEMPORARY UK POPULATION TO INFORM HEALTH TECHNOLOGY ASSESSMENTS
.
VALUE IN HEALTH
.
vol.
25
,
S12
-
S12
.
Zhou J, Wu R, Williams C, Mihaylova B
(
2022
)
.
P55 Excess Annual Hospital Costs Due to Cardiovascular Events in a Contemporary UK Population to Inform Health Technology Assessments
.
Value in Health
.
vol.
25
,
Wu R, Williams C, Schlackow I, Zhou J, Emberson J, Reith C, Keech A, Robson J et al.
(
2022
)
.
P70 Calibrating Cardiovascular Disease Policy Model Using Large Cohort Data
.
Value in Health
.
vol.
25
,
s16
-
s16
.
Azhir A, Talebi S, Merino LH, Lukasiewicz T, Argulian E, Narula J, Mihaylova B
(
2022
)
.
Using Shapes of COVID-19 Positive Patient-Specific Trajectories for Mortality Prediction
.
AMIA ... Annual Symposium proceedings. AMIA Symposium
vol.
2022
,
130
-
139
.
Wu R, Rison S, Raisi-Estabragh Z, Dostal I, Carvalho C, Robson J, Mihaylova B
(
2021
)
.
Gaps in antihypertensive and statin treatments and benefits of optimisation: a modelling study in a 1 million ethnically diverse urban population in UK
.
BMJ Open
Norton C, Syred J, Kerry S, Artom M, Sweeney L, Hart A, Czuber-Dochan W, Taylor SJC et al.
(
2021
)
.
Supported online self-management versus care as usual for symptoms of fatigue, pain and urgency/incontinence in adults with inflammatory bowel disease (IBD-BOOST): study protocol for a randomised controlled trial
.
Trials
vol.
22
,
(
1
)
Wu R, Williams C, Schlackow I, Zhou J, Emberson J, Reith C, Keech A, Robson J et al.
(
2021
)
.
A model of lifetime health outcomes in cardiovascular disease based on clinical trials and large cohorts
.
European Heart Journal
.
vol.
42
,
Wu R, Rison S, Raisi-Estabragh Z, Dostal I, Carvalho C, Robson J, Mihaylova B
(
2021
)
.
Benefits from optimised antihypertensive and statin treatment in high risk people
.
EUROPEAN HEART JOURNAL
.
Conference:
European Society of Cardiology Congress 2021
vol.
42
,
2728
-
2728
.
Wu R, Rison S, Raisi-Estabragh Z, Dostal I, Carvalho C, Robson J, Mihaylova B
(
2021
)
.
Benefits from optimised antihypertensive and statin treatment in high risk people
.
European Heart Journal
.
vol.
42
,
ehab724.2728
-
ehab724.2728
.
Lui NMJ, Williams C, Keng MJ, Hopewell J, Bowman L, Landray M, Gray A, Mihaylova B et al.
(
2021
)
.
Impact of adverse events on quality of life and hospital costs in secondary cardiovascular disease prevention
.
European Heart Journal
vol.
42
,
(
Supplement_1
)
Leal J, Alva M, Gregory V, Hayes A, Mihaylova B, Gray AM, Holman RR, Clarke P
(
2021
)
.
Estimating risk factor progression equations for the UKPDS Outcomes Model 2 (UKPDS 90)
.
Diabetic Medicine
vol.
38
,
(
10
)
Halliday A, Bulbulia R, Bonati LH, Chester J, Cradduck-Bamford A, Peto R, Pan H, Potter J et al.
(
2021
)
.
Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy
.
The Lancet
vol.
398
,
(
10305
)
1065
-
1073
.
Perera R, Stevens R, Aronson JK, Banerjee A, Evans J, Feakins BG, Fleming S, Glasziou P et al.
(
2021
)
.
Long-term monitoring in primary care for chronic kidney disease and chronic heart failure: a multi-method research programme
.
Norton C, Syred J, Kerry S, Artom M, Sweeney L, Hart A, Czuber-Dochan W, Taylor SJC et al.
(
2021
)
.
Supported Online Self-Management Versus Care as Usual for Symptoms of Fatigue, Pain and Urgency/incontinence in Adults With Inflammatory Bowel Disease (IBD-BOOST): Study Protocol for a Randomized Controlled Trial
.
Thorn JC, Davies CF, Brookes ST, Noble SM, Dritsaki M, Gray E, Hughes DA, Mihaylova B et al.
(
2021
)
.
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey
.
Value in Health
vol.
24
,
(
4
)
539
-
547
.
Alonso Fernandez S, Tan M, Wang C, Kent S, Cobiac L, Macgregor G, He F, Mihaylova B
(
2021
)
.
Impact of the 2003-2018 population salt intake reduction programme in England: a modelling study
.
Hypertension
Colligan G, Tsocheva I, Scales J, Chavda J, Dove R, Kalsi H, Wood H, Cross L et al.
(
2021
)
.
Investigating the impact of London’s Ultra Low Emission Zone on children’s health: Children’s Health in London and Luton (CHILL): Protocol for a prospective parallel cohort study
.
Shlipak MG, Tummalapalli SL, Boulware LE, Grams ME, Ix JH, Jha V, Kengne AP, Madero M et al.
(
2021
)
.
The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
.
Kidney International
vol.
99
,
(
1
)
34
-
47
.
Schlackow I, Simons C, Oke J, Feakins B, O’Callaghan CA, Richard Hobbs FD, Lasserson D, Stevens RJ et al.
(
2020
)
.
Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data
.
PLoS Medicine
vol.
17
,
(
12
)
Lieberman D, Mangat H, Allen-Philbey K, Baker D, Barkhof F, Chandran S, Chapman C, Chataway J et al.
(
2020
)
.
Cladribine to halt deterioration in people with advanced multiple sclerosis (CHARIOTMS)
.
MULTIPLE SCLEROSIS JOURNAL
.
vol.
26
,
212
-
213
.
Thalmann I, Preiss D, Schlackow I, Gray A, Mihaylova B
(
2020
)
.
Determinants of statin initiation and discontinuation in the secondary prevention of atherosclerotic cardiovascular disease in Scotland during 2009–2017
.
European Heart Journal
vol.
41
,
(
Supplement_2
)
Tsiachristas A, West H, Oikonomou EK, Mihaylova B, Sabharwall N, Channon K, Neubauer S, Antoniades C
(
2020
)
.
Real world cost and health outcomes of patients presented with chest pain in England: which is the most cost-effective first-line test?
.
European Heart Journal
vol.
41
,
(
Supplement_2
)
O'Halloran R, Mihaylova B, Cairns BJ, Kent S
(
2020
)
.
BMI and Cause-Specific Hospital Admissions and Costs: The UK Biobank Cohort Study
.
Obesity (Silver Spring, Md.)
vol.
28
,
(
7
)
1332
-
1341
.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG et al.
(
2020
)
.
2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
.
Russian Journal of Cardiology
vol.
25
,
(
5
)
Levy M, Chen Y, Clarke R, Bennett D, Tan Y, Guo Y, Bian Z, Lv J et al.
(
2020
)
.
Socioeconomic differences in health-care use and outcomes for stroke and ischaemic heart disease in China during 2009–16: a prospective cohort study of 0.5 million adults
.
The Lancet Global Health
vol.
8
,
(
4
)
e591
-
e602
.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG et al.
(
2020
)
.
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” (Atherosclerosis (2019) 290 (140–205), (S0021915019314595), (10.1016/j.atherosclerosis.2019.08.014))
.
Atherosclerosis
vol.
294
,
80
-
82
.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG et al.
(
2020
)
.
2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
.
European Heart Journal
vol.
41
,
(
1
)
111
-
188
.
Authors/Task Force Members, ESC National Cardiac Societies, ESC Committee for Practice Guidelines (CPG)
(
2019
)
.
Erratum to "2019 ESC/EAS guidelines for the management of dyslipidemias: Lipid modification to reduce cardiovascular risk" [Atherosclerosis 290 (2019) 140-205]
.
Atherosclerosis
vol.
292
,
160
-
162
.
Roukas C, Tomini F, Mihaylova B
(
2019
)
.
P49 UK cost-effectiveness value pyramid of asthma interventions
.
Thorax
.
Conference:
Driving quality improvement through education and training
vol.
74
,
Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies
(
2019
)
.
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
.
Atherosclerosis
vol.
290
,
140
-
205
.
Keng MJ, Tsiachristas A, Leal J, Gray A, Mihaylova B
(
2019
)
.
Impact of achieving primary care targets in type 2 diabetes on health outcomes and healthcare costs
.
Diabetes, Obesity and Metabolism
vol.
21
,
(
11
)
2405
-
2412
.
Levy M, Chen Y, Clarke R, Bennett D, Tan Y, Guo Y, Bian Z, Lv J et al.
(
2019
)
.
Declining socioeconomic inequalities in hospital care use and case fatality rates for stroke and ischaemic heart disease in China during 2009–16: a prospective study of 0·5 million adults
.
The Lancet
.
vol.
394
,
Thorn J, Davies CF, Brookes ST, Dritsaki M, Gray E, Hughes D, Noble SM, Petrou S et al.
(
2019
)
.
Essential items for a Health Economics Analysis Plan (HEAP): expert Delphi consensus survey
.
TRIALS
.
vol.
20
,
Hopewell JC, Ibrahim M, Hill M, Shaw PM, Braunwald E, Blaustein RO, Bowman L, Landray MJ et al.
(
2019
)
.
Impact of ADCY9 genotype on response to anacetrapib
.
Circulation
vol.
140
,
(
11
)
891
-
898
.
Oke JL, Feakins BG, Schlackow I, Mihaylova B, Simons C, O'Callaghan CA, Lasserson DS, Hobbs FDR et al.
(
2019
)
.
Statistical models for the deterioration of kidney function in a primary care population: A retrospective database analysis
.
F1000Research
vol.
8
,
1618
-
1618
.
Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, Collins R, Landray MJ et al.
(
2019
)
.
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
.
Kidney Int
vol.
96
,
(
1
)
170
-
179
.
Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, Collins R, Landray M et al.
(
2019
)
.
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease
.
Kidney International
Edwards MR, Forbes G, MacDonald N, Berdunov V, Mihaylova B, Dias P, Thomson A, Grocott MP et al.
(
2019
)
.
Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery
.
BMJ Open
vol.
9
,
(
1
)
e023455
-
e023455
.
Keng MJ, Tsiachristas A, Leal J, Gray AM, Mihaylova B
(
2019
)
.
Impact of variation in Type 2 diabetes care on health outcomes and healthcare costs
.
DIABETIC MEDICINE
.
vol.
36
,
161
-
161
.
Kent S, Aveyard P, Astbury N, Mihaylova B, Jebb SA
(
2019
)
.
Is Doctor Referral to a Low-Energy Total Diet Replacement Program Cost-Effective for the Routine Treatment of Obesity?
.
Obesity
vol.
27
,
(
3
)
391
-
398
.
MIHAYLOVA BA
(
2019
)
.
Efficacy and safety of statin therapy in older people: meta-analysis of individual participant data from 28 randomised controlled trials
.
Lancet407
-
415
.
Oke JL, Feakins BG, Schlackow I, Mihaylova B, Simons C, O'Callaghan CA, Lasserson DS, Hobbs FDR et al.
(
2019
)
.
Statistical models for the deterioration of kidney function in a primary care population: A retrospective database analysis
.
F1000Res
vol.
8
,
Kent S, Jebb S, Gray A, Green J, REEVES G, Beral V, Cairns B, MIHAYLOVA B
(
2018
)
.
Body Mass Index and use and costs of primary care services among women aged 55 to 79 years in England: a cohort and linked data study
.
International Journal of Obesity
Castellani J, Mihaylova B, Siribié M, Gansane Z, Ouedraogo AZ, Fouque F, Sirima SB, Evers SMAA et al.
(
2018
)
.
Household costs and time to treatment for children with severe febrile illness in rural Burkina Faso: The role of rectal artesunate 11 Medical and Health Sciences 1103 Clinical Sciences
.
Malaria Journal
vol.
17
,
(
1
)
Herrington WG, Donovan K, Mihaylova B
(
2018
)
.
Authors’ reply
.
Journal of the American Society of Nephrology
vol.
29
,
(
10
)
2602
-
2603
.
Mihaylova B, Collaborative HT-R
(
2018
)
.
Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy
.
EUROPEAN HEART JOURNAL
.
vol.
39
,
1054
-
1054
.
Mihaylova B
(
2018
)
.
P5083Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy
.
European Heart Journal
vol.
39
,
(
suppl_1
)
Jepson M, Elliott D, Conefrey C, Wade J, Rooshenas L, Wilson C, Beard D, Blazeby JM et al.
(
2018
)
.
An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment
.
Journal of Clinical Epidemiology
vol.
99
,
75
-
83
.
Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, Landray MJ, Moe SM et al.
(
2018
)
.
Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
.
Journal of the American Society of Nephrology
vol.
29
,
(
7
)
2000
-
2013
.
Lokuge K, de Waard DD, Halliday A, Gray A, Bulbulia R, Mihaylova B
(
2018
)
.
Meta-Analysis of the Procedural Risks of Carotid Endarterectomy and Carotid Artery Stenting Over Time
.
Journal of Vascular Surgery
.
vol.
67
,
1934
-
1935
.
Morton RL, Schlackow I, Gray A, Emberson J, Herrington W, Staplin N, Reith C, Howard K et al.
(
2018
)
.
Impact of CKD on Household Income
.
Kidney International Reports
vol.
3
,
(
3
)
610
-
618
.
Lokuge K, de Waard DD, Halliday A, Gray A, Bulbulia R, Mihaylova B
(
2018
)
.
Meta-analysis of the procedural risks of carotid endarterectomy and carotid artery stenting over time
.
British Journal of Surgery
vol.
105
,
(
1
)
26
-
36
.
Schlackow I, Kent S, Herrington W, Emberson J, Haynes R, Reith C, Wanner C, Fellström B et al.
(
2017
)
.
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney disease
.
Heart
vol.
103
,
(
23
)
1880
-
1890
.
Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP et al.
(
2017
)
.
Effects of anacetrapib in patients with atherosclerotic vascular disease
.
New England Journal of Medicine
vol.
377
,
(
13
)
1217
-
1227
.
Kent S, Fusco F, Gray A, Jebb SA, Cairns BJ, Mihaylova B
(
2017
)
.
Body mass index and healthcare costs: a systematic literature review of individual participant data studies
.
Obesity Reviews
vol.
18
,
(
8
)
869
-
879
.
Clayton GL, Smith IL, Higgins JPT, Mihaylova B, Thorpe B, Cicero R, Lokuge K, Forman JR et al.
(
2017
)
.
The INVEST project: Investigating the use of evidence synthesis in the design and analysis of clinical trials
.
Trials
vol.
18
,
(
1
)
Schlackow I, Mihaylova B, Grp SHARPC
(
2017
)
.
A lifetime disease model based on an RCT: development, validation and applications
.
TRIALS
.
vol.
18
,
Thorn J, Ridyard C, Hughes D, Wordsworth S, Mihaylova B, Noble SM, Hollingworth W
(
2017
)
.
Health economics analysis plans: the current state of play
.
TRIALS
.
vol.
18
,
Schlackow I, Gray A, Sharples L, Jackson C, Welton N, Mihaylova B
(
2017
)
.
Methods for extrapolation from clinical trial data to inform economic evaluations: a taxonomy
.
TRIALS
.
vol.
18
,
de Waard DD, Halliday A, de Borst GJ, Bulbulia R, Huibers A, Casana R, Bonati LH, Tolva V et al.
(
2017
)
.
Choices of Stent and Cerebral Protection in the Ongoing ACST-2 Trial: A Descriptive Study
.
Eur J Vasc Endovasc Surg
vol.
53
,
(
5
)
617
-
625
.
Kent S, Green J, Reeves G, Beral V, Gray A, Jebb SA, Cairns BJ, Mihaylova B et al.
(
2017
)
.
Hospital costs in relation to body-mass index in 1·1 million women in England: a prospective cohort study
.
The Lancet Public Health
vol.
2
,
(
5
)
e214
-
e222
.
Bowman L, Chen F, Sammons E, Hopewell JC, Wallendszus K, Stevens W, Valdes-Marquez E, Wiviott S et al.
(
2017
)
.
Randomized Evaluation of the Effects of Anacetrapib through Lipid-modification (REVEAL)—A large-scale, randomized, placebo-controlled trial of the clinical effects of anacetrapib among people with established vascular disease: Trial design, recruitment, and baseline characteristics
.
American Heart Journal
vol.
187
,
182
-
190
.
Achelrod D, Gray A, Preiss D, Mihaylova B
(
2017
)
.
Cholesterol- and blood-pressure-lowering drug use for secondary cardiovascular prevention in 2004-2013 Europe
.
European Journal of Preventive Cardiology
vol.
24
,
(
4
)
426
-
436
.
Herrington WG, Emberson J, Mihaylova B, Collins R, Baigent C
(
2016
)
.
Are statins useful in patients with advanced chronic kidney disease? – Authors' reply
.
The Lancet Diabetes and Endocrinology
vol.
4
,
(
12
)
971
-
972
.
Thorn J, Ridyard C, Hughes D, Wordsworth S, Mihaylova B, Noble S, Hollingworth W
(
2016
)
.
PRM221 Health Economics Analysis Plans: Where Are We Now?
.
Value in Health
.
vol.
19
,
Lokuge K, de Waard D, Bulbulia R, Gray A, Halliday A, Mihaylova B
(
2016
)
.
Procedural risks of carotid endarterectomy and carotid artery stenting have improved since 2005: Results from a systematic review of observational studies
.
INTERNATIONAL JOURNAL OF STROKE
.
vol.
11
,
S25
-
S25
.
Herrington WG, Emberson J, Mihaylova B, Blackwell L, Reith C, Solbu MD, Mark PB, Fellström B et al.
(
2016
)
.
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
.
The Lancet Diabetes and Endocrinology
vol.
4
,
(
10
)
829
-
839
.
Kent S, Haynes R, Hopewell JC, Parish S, Gray A, Landray MJ, Collins R, Armitage J et al.
(
2016
)
.
Effects of vascular and nonvascular adverse events and of extended-release niacin with laropiprant on health and healthcare costs
.
Circulation: Cardiovascular Quality and Outcomes
vol.
9
,
(
4
)
348
-
354
.
Reith C, Blackwell L, Emberson J, Mihaylova B, Armitage J, Fulcher J, Keech A, Simes J et al.
(
2016
)
.
Protocol for analyses of adverse event data from randomized controlled trials of statin therapy
.
American Heart Journal
vol.
176
,
63
-
69
.
Mihaylova B, Schlackow I, Herrington W, Lozano-Kühne J, Kent S, Emberson J, Reith C, Haynes R et al.
(
2016
)
.
Cost-effectiveness of simvastatin plus ezetimibe for cardiovascular prevention in CKD: Results of the study of heart and renal protection (SHARP)
.
American Journal of Kidney Diseases
vol.
67
,
(
4
)
576
-
584
.
Morton RL, Schlackow I, Staplin N, Gray A, Cass A, Haynes R, Emberson J, Herrington W et al.
(
2016
)
.
Impact of Educational Attainment on Health Outcomes in Moderate to Severe CKD
.
American Journal of Kidney Diseases
vol.
67
,
(
1
)
31
-
39
.
Castellani J, Nsungwa-Sabiiti J, Mihaylova B, Ajayi IO, Siribié M, Afonne C, Balyeku A, Sermé L et al.
(
2016
)
.
Impact of improving community-based access to malaria diagnosis and treatment on household costs
.
Clinical Infectious Diseases
vol.
63
,
S256
-
S263
.
Castellani J, Mihaylova B, Ajayi IO, Siribié M, Nsungwa-Sabiiti J, Afonne C, Sermé L, Balyeku A et al.
(
2016
)
.
Quantifying and valuing community healthworker time in improving access to malaria diagnosis and treatment
.
Clinical Infectious Diseases
vol.
63
,
S298
-
S305
.
Morton RL, Schlackow I, Mihaylova B, Staplin ND, Gray A, Cass A
(
2016
)
.
The impact of social disadvantage in moderate-to-severe chronic kidney disease: An equity-focused systematic review
.
Nephrology Dialysis Transplantation
vol.
31
,
(
1
)
46
-
56
.
Lokuge K, Halliday A, Bulbulia R, Gray A, Mihaylova B
(
2015
)
.
Systematic review of randomised and observational evidence of effects of treatments of carotid stenosis to prevent stroke
.
Trials
.
vol.
16
,
Morton RL, Schlackow I, Staplin N, Gray A, Cass A, Haynes R, Emberson J, Herrington W et al.
(
2015
)
.
FP329IMPACT OF EDUCATIONAL ATTAINMENT ON HEALTH OUTCOMES IN MODERATE-TO-SEVERE CHRONIC KIDNEY DISEASE
.
Nephrology Dialysis Transplantation
.
vol.
30
,
iii178
-
iii178
.
Kent S, Schlackow I, Lozano-Kühne J, Reith C, Emberson J, Haynes R, Gray A, Cass A et al.
(
2015
)
.
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
.
BMC Nephrology
vol.
16
,
(
1
)
Castellani J, Mihaylova B, Evers SMAA, Paulus ATG, Mrango ZE, Kimbute O, Shishira JP, Mulokozi F et al.
(
2015
)
.
Out-of-pocket costs and other determinants of access to healthcare for children with febrile illnesses: A case-control study in rural Tanzania
.
PLoS ONE
vol.
10
,
(
4
)
Alva ML, Gray A, Mihaylova B, Leal J, Holman RR
(
2015
)
.
The impact of diabetes-related complications on healthcare costs: New results from the UKPDS (UKPDS 84)
.
Diabetic Medicine
vol.
32
,
(
4
)
459
-
466
.
PLOS ONE Staff
(
2015
)
.
Correction: Out-of-Pocket Costs and Other Determinants of Access to Healthcare for Children with Febrile Illnesses: A Case-Control Study in Rural Tanzania
.
PLoS One
vol.
10
,
(
5
)
Fulcher J, O'Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R et al.
(
2015
)
.
Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174 000 participants in 27 randomised trials
.
The Lancet
vol.
385
,
(
9976
)
1397
-
1405
.
Lokuge K, Halliday A, Bulbulia R, Gray A, Mihaylova B
(
2015
)
.
Systematic review of randomised and observational evidence of effects of treatments of carotid stenosis to prevent stroke
.
Trials
vol.
16
,
(
Suppl 2
)
P164
-
P164
.
Alva M, Gray A, Mihaylova B, Clarke P
(
2014
)
.
The effect of diabetes complications on health-related quality of life: The importance of longitudinal data to address patient heterogeneity
.
Health Economics (United Kingdom)
vol.
23
,
(
4
)
487
-
500
.
Schlackow I, Mihaylova B
(
2013
)
.
Developing a lifetime disease model from RCT data using parametric models with time-updated covariates
.
Trials
vol.
14
,
(
Suppl 1
)
O24
-
O24
.
Halliday A, Bulbulia R, Gray W, Naughten A, Den Hartog A, Delmestri A, Wallis C, Le Conte S et al.
(
2013
)
.
Status update and interim results from the asymptomatic carotid surgery trial-2 (ACST-2)
.
European Journal of Vascular and Endovascular Surgery
vol.
46
,
(
5
)
510
-
518
.
Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A et al.
(
2012
)
.
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials
.
The Lancet
vol.
380
,
(
9841
)
581
-
590
.
Mihaylova B, Emberson J, Keech A, Collins R, Baigent C
(
2012
)
.
Authors' reply
.
The Lancet
vol.
380
,
(
9856
)
1817
-
1818
.
Heart Protection Study Collaborative Group
(
2011
)
.
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial
.
Lancet
vol.
378
,
(
9808
)
2013
-
2020
.
Mihaylova B, Briggs A, O'Hagan A, Thompson SG
(
2011
)
.
Review of statistical methods for analysing healthcare resources and costs
.
Health Economics
vol.
20
,
(
8
)
897
-
916
.
Alva M, Gray AM, Mihaylova B, Holman RR
(
2011
)
.
Outpatient Resource Utilization of Type-2 Diabetes Patients: New Evidence from the UKPDS
.
DIABETES
.
vol.
60
,
A67
-
A67
.
Alva ML, Gray A, Mihaylova B, Clarke P
(
2011
)
.
The effect of diabetes complications on health-related quality of life: estimating the bias due to unobserved heterogeneity using the UKPDS
.
Trials
vol.
12
,
(
Suppl 1
)
A64
-
A64
.
Buchanan J, Mihaylova B, Gray A, White N
(
2010
)
.
Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness
.
PLoS ONE
vol.
5
,
(
12
)
Maude RJ, Mihaylova B, Warsame M, Singlovic J, Pongtavornpinyo W, Saralamba S, Dondorp AM, White NJ et al.
(
2010
)
.
RECTAL AND INTRAVENOUS ARTESUNATE FOR SEVERE MALARIA: MODELLING THE IMPACT OF ARTEMISININ RESISTANCE
.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
.
vol.
83
,
377
-
377
.
Alva ML, Gray A, Mihaylova B, Clarke P
(
2010
)
.
Estimating the quality of life impact of diabetes related complications: new results from the UKPDS
.
DIABETOLOGIA
.
vol.
53
,
S52
-
S52
.
Mihaylova B, Pitman R, Tincello D, Van Der Vaart H, Tunn R, Timlin L, Quail D, Johns A et al.
(
2010
)
.
Cost-effectiveness of duloxetine: The stress urinary incontinence treatment (SUIT) study
.
Value in Health
vol.
13
,
(
5
)
565
-
572
.
Mihaylova B, Briggs A, Hlatky M, Armitage M, Parish S, Gray A, Collins R, Collins R et al.
(
2009
)
.
Statin cost-effectiveness in the United States for people at different vascular risk levels
.
Circulation: Cardiovascular Quality and Outcomes
vol.
2
,
(
2
)
65
-
72
.
Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, Deckers J, Ferrari R et al.
(
2007
)
.
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
.
Heart
vol.
93
,
(
9
)
1081
-
1086
.
Mihaylova B, Briggs A, Armitage J, Parish S, Gray A, Collins R
(
2006
)
.
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from randomised trial of 20 536 people
.
British Medical Journal
vol.
333
,
(
7579
)
1145
-
1148
.
Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, Ferrari R, Remme W et al.
(
2006
)
.
The cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
.
HEART
.
vol.
92
,
A36
-
A36
.
Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, Ferrari R, Remme WJ et al.
(
2006
)
.
The cost-effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
.
vol.
47
,
260A
-
260A
.
Mihaylova B, Armitage J, Briggs A, Gray A, Parish S, Collins R, Collaborati HPS
(
2005
)
.
Economic analysis of simvastatin in 20,536 people at different levels of vascular disease risk based on US costs: Randomised placebo-controlled trial
.
CIRCULATION
.
vol.
112
,
U900
-
U901
.
Mihaylova B, Briggs A, Armitage J, Parish S, Gray A, Collins R, Collins R, Meade T et al.
(
2005
)
.
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: Economic analysis of a randomised trial in 20 536 individuals
.
Lancet
vol.
365
,
(
9473
)
1779
-
1785
.
Briggs A, Armitage J, Gray A, Mihaylova B, Parish S, Young A, Collins R, Collaborati HPS
(
2003
)
.
Economic evaluation of the Heart Protection Study
.
CIRCULATION
.
vol.
108
,
776
-
776
.
Collins R, Armitage J, Parish S, Sleigh P, Peto R, Heart Protection Study Collaborative Group
(
2003
)
.
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
.
Lancet
vol.
361
,
(
9374
)
2005
-
2016
.
Heart Protection Study Collaborative Group
(
2002
)
.
MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial
.
Lancet
vol.
360
,
(
9326
)
23
-
33
.
Heart Protection Study Collaborative Group
(
2002
)
.
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial
.
Lancet
vol.
360
,
(
9326
)
7
-
22
.
Bryant J, Loveman E, Chase D, Mihaylova B, Cave C, Gerard K, Milne R
(
2002
)
.
Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: A systematic review and economic evaluation
.
Health Technology Assessment
vol.
6
,
(
19
)
Bryant J, Cave C, Mihaylova B, Chase D, McIntyre L, Gerard K, Milne R
(
2002
)
.
Clinical effectiveness and cost-effectiveness of growth hormone in children: A systematic review and economic evaluation
.
Health Technology Assessment
vol.
6
,
(
18
)